|
EpiCeram
EpiCeram Skin Barrier Emulsion is a steroid-free, fragrance-free, ceramide-dominant topical formulation. It is indicated to treat dry skin conditions and to manage and relieve the burning and itching associated with various types of dermatoses, including atopic dermatitis. EpiCeram Skin Barrier Emulsion helps to relieve dry, waxy skin by maintaining a moist wound and skin environment, which is beneficial to the healing process.
Visit the EpiCeram website at www.epiceram.ca
|
|

|
|
NYDA
Indicated for the treatment and eradication of head lice, will be filed with Health Canada in the first half of 2009. NYDA is presently under evaluation by Health Canada
|
|

|
|
Suprax
Indicated for the treatment of pharyngitis, tonsillitis, otitis media, sinusitis and acute bronchitis caused by susceptible strains of S. pyogenes, S. pneumoniae, H. influenzae and M. catarrhalis
|
|

|
|
Kool-Effects Patch (OTC)
Innovative biogel patch that reduces the symptoms of fever or headaches. Launch planned for 2010
|
|

|
|
VapoLyptus Patch (OTC)
Innovative product promoting the clearing of air passages in children with cold symptoms or allergies during bedtime. Launch planned for 2010
|
|

|